Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: uniQure N.V., 3 years.
uniQure N.V.
Director
Rallybio Corporation
Director
Dianthus Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 8, 2026 | Dianthus Therapeutics Inc. | Option exercise | +599 | $8.44 | $5,056 |
| May 8, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −599 | $85.47 | $51,197 |
| Mar 31, 2026 | Dianthus Therapeutics Inc. | Option exercise | +599 | $8.44 | $5,056 |
| Mar 31, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −599 | $80.11 | $47,986 |
| Mar 24, 2026 | Dianthus Therapeutics Inc. | Option exercise | +27,594 | $8.44 | $232,893 |
| Mar 24, 2026 | Dianthus Therapeutics Inc. | Open-market sale | −27,594 | $78.05 | $2,153,712 |
| Jun 13, 2024 | uniQure N.V. | Open-market sale | −2,220 | $5.14 | $11,411 |
| Jun 16, 2023 | uniQure N.V. | Open-market sale | −2,275 | $18.99 | $43,202 |
| Jun 13, 2023 | uniQure N.V. | Grant or award | +8,700 | — | — |
| Feb 27, 2023 | uniQure N.V. | Open-market sale | −384 | $19.97 | $7,668 |
| Jan 18, 2023 | uniQure N.V. | Option exercise | +6,000 | $5.37 | $32,220 |
| Jan 18, 2023 | uniQure N.V. | Open-market sale | −6,000 | $22.59 | $135,540 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.